Gyre Therapeutics Inc — Cash Flow (NASDAQ:GYRE)

Financials

Overview Estratto Conto Statistics Dividends

Cash from operating activities -55.05 M-83.75 M-33.1 M25.89 M-3.64 M 3.88 M Cash from investing activities 9.66 M48.19 M55.43 M-19.76 M-19.88 M -4.33 M Cash from financing activities 60.38 M49.55 M-45.01 M2.5 M2.1 M 25.02 M Free cash flow -55.05 M-83.75 M-33.1 M17.31 M-6.77 M 2.16 M